BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications

被引：0
|
作者：
Farghaly, SA [1 ]
机构：
[1] DHCC, New York, NY 10017 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1998年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0002-9378(98)70229-7
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1101 / 1101
页数：1
相关论文
共 50 条
  • [41] Clinical relevance of ten BRCA1 and three BRCA2 intronic germline mutations in families with hereditary breast and/or ovarian cancer
    Wappenschmidt, B.
    Kohler, J.
    Bosse, K.
    Versmold, B.
    Schmutzler, R. K.
    ONKOLOGIE, 2008, 31 : 29 - 29
  • [42] Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria
    Singer, C. F.
    Muhr, D.
    Rappaport, C.
    Tea, M-K
    Gschwantler-Kaulich, D.
    Fink-Retter, A.
    Pfeiler, G.
    Berger, A.
    Sun, P.
    Narod, S. A.
    CLINICAL GENETICS, 2014, 85 (01) : 72 - 75
  • [43] Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications
    Eugenia Yiannakopoulou
    Cellular Oncology, 2014, 37 : 1 - 8
  • [44] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    CANCER RESEARCH, 2016, 76
  • [45] Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications
    Yiannakopoulou, Eugenia
    CELLULAR ONCOLOGY, 2014, 37 (01) : 1 - 8
  • [46] Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer
    Foster, KA
    Harrington, P
    Kerr, J
    Russell, P
    DiCioccio, RA
    Scott, IV
    Jacobs, I
    ChenevixTrench, G
    Ponder, BAJ
    Gayther, SA
    CANCER RESEARCH, 1996, 56 (16) : 3622 - 3625
  • [47] BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families.
    Schwarz-Boeger, U
    Schmutzler, RK
    Bastert, G
    Bender, HG
    Beckmann, MW
    Caffier, H
    Crohns, C
    Deininger, J
    Dietl, J
    Ditsch, N
    Distler, W
    Estevez-Schwarz, L
    Hepp, H
    Herroeder, N
    Huebbel, V
    Huettner, C
    Jackisch, C
    Jonat, W
    Kandel, M
    Kast, K
    Kaufmann, M
    Krapfl-Gast, AS
    Kreienberg, R
    Kuschel, B
    Kuschel, B
    Luck, H
    Meindl, A
    von Minckwitz, G
    Nestle-Kraemling, C
    Paepke, S
    Prieshof, B
    Rensing, K
    Rhiem, KA
    Schaeffer, MA
    Straub, L
    Untch, M
    Kiechle, T
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S154 - S155
  • [48] BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer
    Pristauz G.
    Geigl J.B.
    Petru E.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 158 - 162
  • [49] A prospective study about BRCA1/BRCA2 germline mutations in hereditary breast/ovarian cancer patients
    Ben Kridis, W.
    Ben Ayed-Guerfali, D.
    Ammous-Boukhris, N.
    Ayedi, W.
    Charfi, S.
    Boudawara, T.
    Daoud, J.
    Khanfir, A.
    Mokdad-Gargouri, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1223 - S1223
  • [50] BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing
    Rubin, SC
    Blackwood, MA
    Bandera, C
    Behbakht, K
    Benjamin, I
    Rebbeck, TR
    Boyd, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (04) : 670 - 677
12345